CARLSBAD, Calif., Sept. 14, 2006 (PRIMEZONE) -- Omni USA, Inc. dba Brendan Technologies, Inc. (OTCBB:OUSA), a pharmaceutical and laboratory testing software company, today announced its name will change to Brendan Technologies, Inc. effective as of the opening of markets on Friday, September 15, 2006. Shares will continue to trade on the Bulletin Board with a new stock ticker symbol -- (OTCBB:BDTE).
"Brendan was the surviving entity after a reverse merger with Omni in December 2005. The products we are currently selling and updating are identified with Brendan and the change in the parent company name was a natural progression to continue product loyalty and exposure of our core product, StatLIA(r)," said John Dunn, President and CEO of Brendan. "StatLIA is recognized for its breakthroughs in technological advancements for the life science industries. Our next release will incorporate these advancements into a completely redesigned .net architecture that adds the improved functionality and ease-of-use our customers in the pharmaceutical and other industries have requested. This new release will meet their demands for a scalable enterprise-wide solution for their analytical software."
Brendan recently received $1 million from the Potawatomi Business Development Corporation to provide funding necessary to advance the next release of its software.
About Brendan Technologies, Inc.
Brendan Technologies, Inc. has been actively involved in providing software solutions to improve the accuracy, quality control, workflow, and regulatory compliance of immunoassay testing in laboratories in the biopharmaceutical, clinical, research, veterinarian and agricultural industries. The Company's innovative software addresses the data analysis, workflow, and regulatory needs of its customers, many of which are Fortune 1000 organizations that represent some of the largest corporations in their respective fields. Brendan Technologies is currently redesigning and expanding its current product lineup to better capitalize on the growing demand of its target markets for more advanced software. More information is available at www.brendan.com.
Forward-looking statement: Except for historical information, this press release contains forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties, which may cause actual results to differ materially from those statements. Those risks and uncertainties include, but are not limited to, changing market conditions and other risks detailed from time to time in the Company's ongoing quarterly filings, annual information form, and annual reports. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events in this press release might not occur.